SEC Info - Chemours Co. - ‘8-K’ for 9/21/22

SEC Info℠

Home

Help

Please Sign In

Chemours Co. – ‘8-K’ for 9/21/22

On: Wednesday, 9/21/22, at 8:06am ET · For: 9/21/22 · Accession #: 950170-22-18696 · File #: 1-36794

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/21/22  Chemours Co.                      8-K:7,9     9/21/22   11:518K                                   Donnelley … Solutions/FA

Current Report — Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     60K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML    122K 
 6: R1          Document and Entity Information                     HTML     45K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- cc-20220921_htm                     XML     15K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 3: EX-101.LAB  XBRL Labels -- cc-20220921_lab                       XML     52K 
 5: EX-101.PRE  XBRL Presentations -- cc-20220921_pre                XML     33K 
 4: EX-101.SCH  XBRL Schema -- cc-20220921                           XSD     11K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               11±    18K 
11: ZIP         XBRL Zipped Folder -- 0000950170-22-018696-xbrl      Zip     63K

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX: C: C: C:

8-K

i 0001627223 i false00016272232022-09-212022-09-21

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM i 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

i September 21, 2022

Date of Report (Date of Earliest Event Reported)

i The Chemours Company

(Exact Name of Registrant as Specified in Its Charter)


i Delaware	i 001-36794	i 46-4845564
(State or Other Jurisdiction	(Commission	(I.R.S. Employer
Of Incorporation)	File Number)	Identification No.)

i 1007 Market Street

i Wilmington, i Delaware i 19801

(Address of principal executive offices)

Registrant’s telephone number, including area code: i (302) i 773-1000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


i ☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i ☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i ☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i ☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of Each Class	Trading Symbol(s)	Name of Exchange on Which Registered
i Common Stock ($0.01 par value)	i CC	i New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company		i ☐


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.		☐

Item 7.01 Regulation FD Disclosure.

On September 21, 2022, The Chemours Company (the “Company”) issued a press release in which it provided updated guidance regarding its expected financial results for the year ending December 31, 2022, which differs from the Company's previously issued guidance. A copy of the press release is furnished hereto as Exhibit 99.1.

The information furnished with this report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and it will not be deemed incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

99.1 Press Release dated September 21, 2022.

104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


THE CHEMOURS COMPANY

By:		/s/ *Sameer Ralhan*
		Sameer Ralhan
		Senior Vice President, Chief Financial Officer
Date:		September 21, 2022

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

	12/31/22	None on these Dates
Filed on / For Period end:	9/21/22
		List all Filings

↑Top

Filing Submission 0000950170-22-018696 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)